Rampart IC Obtains European and Middle Eastern Distributors

“The successful introduction of Rampart will allow health care professional to continue to deliver lifesaving treatments to patients without incurring the risks of chronic exposure to ionizing radiation,” said James Spratt, professor and interventional cardiologist at St Georges, University of London. “This should allow further development of percutaneous treatments and prolong the careers of HCPs working within the field.”